FN1 and myeloid sarcoma: To remove cellular Fn, we targeted astrocytes, because they are considered a major source of Fn in the CNS following injury (Hibbits et al., 2012), and synthesize pathological Fn aggregates in MS (Stoffels et al., 2013a).